Products

News

Echelon Biosciences sub-awarded DoD grant to develop drugs to thwart Impact of trauma, stroke, and Cardiac arrest

Contributed by admin on Sep 13, 2016 - 06:13 PM

Mark Nelson Ph.D., of Echelon Biosciences will be the principal investigator, to synthesize and test drugs to protect the brain and other organs in the body from ischemia and reperfusion injury (IRI).

Full story here
 
assay and reagents for drug discovery in lipid signaling pathways